FOLD · AMICUS THERAPEUTICS, INC.
$14.49
+0.00 (+0.00%)
At close · Apr 27
Market Cap
$4.55B
Shares
314.00M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Bradley Campbell | CEO | $8,526,943 |
| Ellen S. Rosenberg | Chief Legal Officer and Corporate Secretary | $3,800,307 |
| Simon Harford | CFO | $3,449,065 |
| Jeffrey P. Castelli | Chief Development Officer | $3,442,896 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Bradley Campbell | CEO | $8,202,366 |
| Ellen S. Rosenberg | Chief Legal Officer and Corporate Secretary | $4,075,157 |
| Jeffrey P. Castelli | Chief Development Officer | $3,671,762 |
| David M. Clark | Chief People Officer | $3,214,599 |
| Simon Harford | CFO | $2,980,585 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Bradley Campbell | CEO | $8,997,866 |
| Ellen S. Rosenberg | Chief Legal Officer and Corporate Secretary | $3,665,731 |
| Jeffrey P. Castelli | Chief Development Officer | $3,055,703 |
| David M. Clark | Chief People Officer | $2,708,063 |
| Simon Harford | CFO | — |